Harmony Biosciences Holdings, Inc.
HRMY
$38.05
$0.882.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.01% | 19.48% | 19.51% | 16.08% | 28.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.01% | 19.48% | 19.51% | 16.08% | 28.76% |
| Cost of Revenue | 18.69% | 16.41% | 26.09% | 32.46% | 28.53% |
| Gross Profit | 15.40% | 20.14% | 17.24% | 11.95% | 28.81% |
| SG&A Expenses | 14.83% | 17.10% | 3.12% | 22.19% | 17.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.56% | 25.25% | 13.51% | 29.83% | 73.46% |
| Operating Income | 125.60% | 8.09% | 38.64% | -4.34% | -54.47% |
| Income Before Tax | 128.81% | 10.41% | 41.49% | 19.95% | -50.80% |
| Income Tax Expenses | -2.40% | -13.63% | -48.94% | 20.24% | 3.14% |
| Earnings from Continuing Operations | 243.16% | 18.85% | 85.95% | 19.84% | -66.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 243.16% | 18.85% | 85.95% | 19.84% | -66.21% |
| EBIT | 125.60% | 8.09% | 38.64% | -4.34% | -54.47% |
| EBITDA | 97.56% | 6.97% | 33.19% | -4.16% | -48.25% |
| EPS Basic | 239.10% | 17.74% | 89.94% | 26.15% | -64.31% |
| Normalized Basic EPS | 126.14% | 9.38% | 44.53% | 6.24% | -48.05% |
| EPS Diluted | 240.00% | 16.42% | 89.84% | 25.40% | -64.29% |
| Normalized Diluted EPS | 125.38% | 8.67% | 43.04% | 5.41% | -48.07% |
| Average Basic Shares Outstanding | 1.17% | 0.95% | -2.10% | -5.00% | -5.29% |
| Average Diluted Shares Outstanding | 1.54% | 1.61% | -1.08% | -4.25% | -5.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |